Zacks: LDR shares lowered to “sell”: 5 points

Zacks Investment Research has lowered LDR shares to a “sell” rating, according to an Intercooler report.

Advertisement

Here are five points:

 

1. LDR previously had a “hold” rating from Zacks.

 

2. However, LDR has an average rating of “buy” and a consensus target price of $36.94 from all analysts covering its stock.

 

3.  LDR stock has a 52-week low of $16.33 and a 52-week high of $47.12.

 

4. The firm’s 50-day moving average is $20.04, and its 200-day moving average is $28.66.

 

5. The stock’s market cap is $642.18 million.

 

More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.